Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Van Tongelen, I.
De Spiegeleer, B.
Remon, J. P.
Text and Data Mining valid from 2019-08-01
Version of Record valid from 2019-08-01
29 March 2019
9 July 2019
1 August 2019
Ethics approval and consent to participate
The authors declare that they have no competing interests.